| MRKR Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MRKR shares outstanding history going back to 8/2/2018:
Also see: MRKR Market Cap History MRKR YTD Return |
As of 8/7/2026 Marker Therapeutics has 16.67 million MRKR shares outstanding. Investors often track the MRKR shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows MRKR share count trends over time, with 32 historical shares outstanding datapoints presented, dating back to 8/2/2018.

| MRKR Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MRKR shares outstanding history going back to 8/2/2018:
Also see: MRKR Market Cap History MRKR YTD Return |
| MRKR Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MRKR Historical Shares Outstanding: +36.55% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MRKR Stock Price Chart |
| About Marker Therapeutics Inc |
| Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company. Co. specializes in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. It has developed its lead product candidates from its multiTAA-specific T cell technology, which is based on the manufacture of non-engineered, tumor-specific T cells that recognize multiple tumors associated antigens (TAAs), which are tumor targets, and kill tumor cells expressing those targets. We show 32 historical shares outstanding datapoints in our coverage of MRKR's shares outstanding history. Understanding the changing numbers of MRKR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MRKR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MRKR by allowing them to research MRKR shares outstanding history as well as any other stock in our coverage universe. |
| MRKR Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| MRKR Share Performance |
| Shares Outstanding Peers |
| Marker Therapeutics (MRKR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
MRNA Shares Outstanding History MRNS Shares Outstanding History MRSN Shares Outstanding History MRTX Shares Outstanding History MRVI Shares Outstanding History MSON Shares Outstanding History MTCR Shares Outstanding History MTEM Shares Outstanding History MTVA Shares Outstanding History MXCT Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.